Breaking News Instant updates and real-time market news.

ORCL

Oracle

$56.45

0.98 (1.77%)

, YELP

Yelp

$35.85

1.85 (5.44%)

09:01
09/12/19
09/12
09:01
09/12/19
09:01

Fly Intel: Pre-market Movers

HIGHER: Hertz (HTZ), up 2.5% after Carl Icahn boosted his stake in the company to 30.1%... Yelp (YELP), up 2% after after The Wall Street Journal reported on speculation about potential acquisition interest from Groupon (GRPN). The latter is down 3% following the report... Moderna (MRNA), up 2% after announcing data from two Phase 1 studies of its investigational cytomegalovirus vaccine mRNA-1647 and of mRNA-1944 administered via intravenous infusion in healthy adults. UP AFTER EARNINGS: Viavi (VIAV), up 1%... Palatin (PTN), up 4%. DOWN AFTER EARNINGS: Oracle (ORCL), down 2.5%... Tailored Brands (TLRD), down 27%. ALSO LOWER: Tocagen (TOCA), down 81% after announcing that the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma undergoing resection missed the primary endpoint of overall survival compared to standard of care treatment... Baker Hughes (BHGE), down 3% after General Electric (GE) announced the reduction of its ownership in the company through a public offering of 115M shares of Class A common stock of BHGE and a concurrent private sale to BHGE of ownership interests in BHGE. The offering upsized and priced at a price to the public of $21.50 per share.. Universal Display (OLED), down 4% after its shares were downgraded to Negative from Neutral at Susquehanna.

ORCL

Oracle

$56.45

0.98 (1.77%)

YELP

Yelp

$35.85

1.85 (5.44%)

GRPN

Groupon

$2.91

-0.07 (-2.35%)

BHGE

Baker Hughes

$22.00

-1.36 (-5.82%)

GE

General Electric

$9.40

0.26 (2.84%)

HTZ

Hertz

$14.41

0.17 (1.19%)

MRNA

Moderna

$16.34

-0.78 (-4.56%)

VIAV

Viavi

$14.92

0.81 (5.74%)

PTN

Palatin

$1.02

-0.01 (-0.97%)

TLRD

Tailored Brands

$5.33

-1.34 (-20.09%)

TOCA

Tocagen

$4.16

0.395 (10.51%)

OLED

Universal Display

$195.99

4.79 (2.51%)

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 23

    Sep

  • 24

    Sep

  • 30

    Oct

  • 12

    Sep

ORCL Oracle
$56.45

0.98 (1.77%)

09/12/19
LEHM
09/12/19
NO CHANGE
Target $57
LEHM
Equal Weight
Oracle shares will likely remain range-bound, says Barclays
Barclays analyst Raimo Lenschow believes Oracle shares will likely remain range-bound following last night's results. Oracle will likely remain a low single-digit revenue grower that achieves most of its earnings improvement via share buybacks, Lenschow tells investors in a research note titled "Still a Wait-and-See Story." He lowered his price target for the shares to $57 from $59 and keeps an Equal Weigh rating on Oracle.
09/12/19
BMOC
09/12/19
NO CHANGE
Target $60
BMOC
Market Perform
Oracle price target raised to $60 after Q1 results, says BMO Capital
BMO Capital analyst Keith Bachman nudged his price target on Oracle to $60 from $59 but kept his Market Perform rating after its Q1 results and Q2 guidance last night. The analyst points to the management's discussion of share gains being made in the autonomous data base and ERP cloud solutions, stating that while there is potential in these opportunities, the company's execution over the last few years has been "largely disappointing". Bachman adds that Oracle's results over the past two quarters have not produced a "meaningful" change in growth rates.
09/12/19
NOMU
09/12/19
NO CHANGE
Target $42
NOMU
Reduce
Oracle results do not alter bearish thesis, says Nomura Instinet
Nomura Instinet analyst Christopher Eberle says Oracle's results last night did not provide much in the way to alter his bearish thesis. The company's revenue growth has yet to meaningfully inflect despite strong cloud bookings, and its share buyback remains elevated, Eberle tells investors in a research note. He reiterates a Reduce rating on Oracle with a $42 price target.
09/12/19
MSCO
09/12/19
NO CHANGE
Target $59
MSCO
Equal Weight
Oracle continues struggling for growth, says Morgan Stanley
Morgan Stanley analyst Keith Weiss said Oracle suffered from "spotty execution," resulting in a weaker Q1 after a stronger Q4, noting that this is a similar situation to last year. Several factors keep him cautious on the company's FY20 revenue growth potential, including management stepping back from prior full year revenue growth targets, the continued mixed performance in the apps portfolio and another quarter of year-over-year deferred revenue declines, Weiss tells investors. He maintains an Equal Weight rating on Oracle with an unchanged price target of $59.
YELP Yelp
$35.85

1.85 (5.44%)

05/10/19
RILY
05/10/19
DOWNGRADE
RILY
Neutral
Yelp downgraded to Neutral from Buy at B. Riley FBR
08/09/19
DADA
08/09/19
NO CHANGE
Target $48
DADA
Buy
Yelp CFO departure another indication of possible sale, says DA Davidson
DA Davidson analyst Tom Forte views the upcoming departure of CFO Lanny Baker as "another indication that Yelp (YELP) may be sold." Forte believes the company could be worth as much as $60 per share in a buyout. Yelp in afternoon trading is up 8%, or $2.93, to $37.76. Of the companies he covers, Forte says Yelp is the most likely to be sold given the low price of its shares, the involvement of an activist, and its strategic value to potential acquirers like Amazon.com (AMZN), Apple (AAPL), Facebook (FB) or Alphabet (GOOG, GOOGL). The analyst has a Buy rating on Yelp with a $48 price target.
06/04/19
AGIS
06/04/19
UPGRADE
AGIS
Hold
Yelp upgraded to Hold from Sell at Aegis
Aegis analyst Victor Anthony upgraded Yelp to Hold from Sell.
05/10/19
RILY
05/10/19
DOWNGRADE
Target $42
RILY
Neutral
Yelp downgraded to Neutral on declining pricing visibility at B Riley FBR
B Riley FBR analyst Sameet Sinha downgraded Yelp to Neutral from Buy and lowered his price target for the shares to $42 from $50. The analyst says the company's pricing visibility is declining while its request a quote feature is stagnating.
GRPN Groupon
$2.91

-0.07 (-2.35%)

02/04/19
GSCO
02/04/19
INITIATION
Target $3.5
GSCO
Neutral
Groupon initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng started Groupon with a Neutral rating and $3.50 price target. While the company's business model is in transition, its domestic customer base is declining and should continue to do so, particularly as Groupon moderates its domestic marketing spending, Ng tells investors in a research note. However, he believes these "challenges are well understood" at current share levels.
02/04/19
02/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with a Buy at Goldman Sachs while Groupon (GRPN) was initiated with a Neutral, and Match Group (MTCH) and Shutterfly (SFLY) were initiated with a Sell. 2. eHealth (EHTH) initiated with an Outperform at Evercore ISI. 3. Okta (OKTA) initiated with an Equal Weight at Morgan Stanley. 4. Lonestar Resources (LONE) initiated with an Outperform at Cowen. 5. Kopin (KOPN) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/14/18
WEDB
09/14/18
INITIATION
Target $4
WEDB
Neutral
Groupon initiated with a Neutral at Wedbush
Wedbush analyst Ygal Arounian started Groupon with a Neutral rating and $4 price target. Despite an improved margin profile, Groupon has yet to show a steady increase in profit dollars and has not been able to consistently grow the most important part of the business, Local, Arounian tells investors in a research note. The analyst comes out on the sidelines citing Groupon's "current below-ecommerce market growth rates."
09/14/18
DADA
09/14/18
NO CHANGE
Target $8
DADA
Buy
Groupon is 'attractively priced', says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon, saying the stock is "attractively priced" at current levels with free-cash-flow yield above of 14.8%. The analyst adds that he is "encouraged" by the company's hiring of Sarah Butterfass as its Chief Product Officer. He sees the decision as a reflection of the management's efforts to generate "significant" free cash flow or facilitate the sale of the company to a "strategic buyer", which could unlock up to $12 per share in incremental value for investors.
BHGE Baker Hughes
$22.00

-1.36 (-5.82%)

08/28/19
BOFA
08/28/19
DOWNGRADE
BOFA
Neutral
Nabors, Quintana Energy Services, Nine Energy cut to Neutral at BofA/Merrill
BofA/Merrill analyst Chase Mulvehill downgraded Nabors (NBR), Quintana Energy Services (QES), and Nine Energy Services (NINE) to Neutral from Buy in a broader research note, saying E&P companies are increasingly focused on efficiency gains. The analyst notes however that the technology adoption and service integration are still in the "early innings" of reducing capital intensity. Mulvehill adds that the rating change for these U.S. companies is driven by heightened global macro uncertainty and the resulting oil price volatility, stating that he prefers names with international exposure like Schlumberger (SLB) and Baker Hughes (BHGE).
05/01/19
RBCM
05/01/19
NO CHANGE
Target $33
RBCM
Outperform
Baker Hughes price target lowered to $33 from $40 at RBC Capital
RBC Capital analyst Kurt Hallead lowered his price target on Baker Hughes to $33, adjusting the time frame for average forward multiple in his model to late 2017 from mid-2014 since that was the first combined reporting period for the company. The analyst is also keeping his Outperform rating on Baker Hughes and remains positive on its "multiple levers of growth" amid "robust" LNG equipment demand trends.
06/06/19
JEFF
06/06/19
NO CHANGE
Target $32
JEFF
Buy
Baker Hughes remains a top large-cap pick at Jefferies
Jefferies analyst Brad Handler says Baker Hughes remains his top large-cap pick. The company's Middle East growth should benefit from recent awards and the ADNOC partnership, Handler tells investors in a research note. The analyst finds the shares "very attractive" post the selloff in the group. He keeps a Buy rating on Baker Hughes with a $32 price target.
09/11/19
STFL
09/11/19
NO CHANGE
Target $34
STFL
Buy
GE shrinking ownership positive news for Baker Hughes, says Stifel
Stifel analyst Stephen Gengaro noted that General Electric (GE) will cut its ownership stake in Baker Hughes (BHGE) to about 39.5% from 50.3% via Baker Hughes' repurchase of $250M of its Class B common stock and GE's secondary offering of 105M Class A shares. While he said Baker Hughes shares could weaken on the offering, Gengaro views this as positive news for the company, calling it a positive step towards removing the overhang of GE's ownership. He reiterated a Buy rating and $34 price target on Baker Hughes shares.
GE General Electric
$9.40

0.26 (2.84%)

09/05/19
09/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. General Electric (GE) initiated with an Equal Weight at Morgan Stanley. 2. Organigram (OGI) initiated with a Perform at Oppenheimer. 3. Wingstop (WING) initiated with a Market Perform at Raymond James. 4. Boston Scientific (BSX) reinstated with an Overweight at JPMorgan. 5. Cubic (CUB) initiated with a Hold at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/19
MSCO
09/05/19
INITIATION
Target $10
MSCO
Equal Weight
General Electric initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Joshua Pokrzywinski initiated coverage of General Electric with an Equal Weight rating and $10 price target. The stock's risk/reward "appears reasonable," but comes with an "unfavorable catalyst timing" and unresolved risks outside the core business, particularly in Long-Term Care, Pokrzywinski tells investors in a research note. He believes the GE's "reasonable" valuation and strength in its Aviation platform are offset by "opaque potential cash needs" in Long-Term Care and the long-term market and share potential in Power as competition evolves. Most of the uncertainty in the shares resides outside the core business, making GE less of a fundamental call, says the analyst.
09/04/19
SBSH
09/04/19
NO CHANGE
SBSH
Buy
GE making 'meaningful progress' on simplifying company, says Citi
Following a recent breakfast with management, including CEO Larry Culp, Citi analyst Andrew Kaplowitz remains encouraged by General Electric's "positive momentum," despite "still considerable improvements needed." In the near-term, GE's 2019 framework of negative $1B to positive $1B free cash flow and earnings per share of 55c-65c seems largely intact, "albeit with some risks to monitor," especially relative to elevated U.S.-China trade tensions, Kaplowitz tells investors in a research note. The analyst, however, believes simplifying the company remains a high priority and one on he thinks "meaningful progress is underway." Further, longer-term, GE's runway for improving results in 2020 and beyond "could be more significant than we think some investors appreciate," says the analyst. He keeps a Buy rating on shares of General Electric.
HTZ Hertz
$14.41

0.17 (1.19%)

03/04/19
03/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz saying the company on Friday reported much better than expected Q4 results, and its fiscal 2019 same-store-sales and earnings growth outlook was also well above consensus. 2. Hasbro (HAS) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson saying the stock's multiple will expand as "major theatrical events" approach later in the year. 3. Hertz (HTZ) upgraded to Buy from Neutral at Northcoast. 4. Extended Stay America (STAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling citing the company's Q4 earnings report. 5. Kraft Heinz (KHC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he believes FY19 estimates now look achievable following their recent correction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/19
08/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Neutral at Credit Suisse with analyst Douglas Mitchelson saying he sees less risk to estimates now that the fiscal 2020 consensus earnings per share estimate dropped from over $8 per share a year ago to ~$6 per share today. 2. Lyft (LYFT) upgraded to Outperform from Neutral at Wedbush and to Neutral from Underweight at Atlantic Equities. 3. Roku (ROKU) was upgraded to Overweight from Equal Weight at Stephens and to Buy from Neutral at Rosenblatt. 4. Hertz (HTZ) upgraded to Overweight from Equal Weight at Barclays with analyst Brian Johnson saying the company's "impressive" Q2 plus favorable industry dynamics offers a "better runway for transformation." 5. Dollar General (DG) upgraded to Buy from Neutral at Goldman Sachs with analyst Christopher Prykull saying the broader market volatility that has brought shares of Dollar General down has created an opportunity for investors to step into a "favorably positioned" retailer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/19
LEHM
08/08/19
UPGRADE
Target $19
LEHM
Overweight
Hertz upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Brian Johnson upgraded Hertz Global Holdings to Overweight from Equal Weight with an unchanged price target of $19. The company's "impressive" Q2 plus favorable industry dynamics offers a "better runway for transformation," Johnson tells investors in a research note. The analyst views Hertz as a turnaround story "incrementally validated" by recent events, and he believes the recent share weakness presents a buying opportunity.
07/11/19
BARD
07/11/19
NO CHANGE
Target $17
BARD
Outperform
Verra's Outperform rating backed following Hertz announcement, says Baird
Baird analyst David Koning reiterated an Outperform rating and $17 price target on Verra Mobility (VRRA) following the announcement that Hertz (HTZ) customers, as well as customers of the company's Dollar and Thrifty, can now rent a car using a debit card across European countries. In a research note to investors, Koning notes that the countries where debit is now accepted include Belgium, Czech Republic, France, Germany, Italy and the U.K. which, based on World Bank data, represent about 70% of the EU population. The analyst notes that one of the keys to Verra's tolling business is that customers must have a credit or debit card on file to pay for the tolls.
MRNA Moderna
$16.34

-0.78 (-4.56%)

08/16/19
PIPR
08/16/19
NO CHANGE
Target $30
PIPR
Overweight
Moderna should be bought ahead of catalysts, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends buying shares of Moderna on weakness ahead of the company's R&D day on September 12. Moderna has completed enrollment of the Phase I study of cytomegalovirus vaccine mRNA-1647 with data soon, and the company could also report preliminary Phase I data on intratumoral mRNA-2754 by the end of 2019, Tenthoff tells investors in a research note. Further, the analyst is focused on the Phase I chikungunya antibody mRNA-1944 data in Q4 for read-through to Moderna's orphan disease pipeline. He sees multiple clinical data readouts through the end of the year and reiterates an Overweight rating on the shares with a $30 price target.
05/29/19
OPCO
05/29/19
NO CHANGE
Target $31
OPCO
Outperform
Moderna price target raised to $31 from $27 at Oppenheimer
Oppenheimer analyst Hartaj Singh raised his price target for Moderna to $31 from $27 after spending time with management. The analyst was "consistently impressed" with the updates on safety, manufacturing, and increasing dosing experience of various Moderna therapeutics in different modalities. He reiterates an Outperform rating on the shares.
07/24/19
MSCO
07/24/19
NO CHANGE
MSCO
Warming could create need for up to $125B more vaccinations, says Morgan Stanley
Morgan Stanley analysts led by Matthew Harrison offered a report sizing the impact on biopharma from climate change. They conclude that warmer temperatures are likely to create more hospitable environments for disease transmission and they cite recent research that suggests 385M-725M more people than today may be exposed to infectious diseases such as dengue, Zika, chickungunya, and yellow fever by 2050. They estimate $50B-$125B of incremental vaccinations may be needed, but see the potential for that figure to be as high as $200B with branded pricing of more complicated vaccines. The companies best positioned to benefit from a rising need for infectious disease vaccines include Sanofi (SNY), GlaxoSmithKline (GSK), Moderna (MRNA), Merck (MRK), Johnson & Johnson's (JNJ) Janssen, Pfizer (PFE) and Takeda (TAK), according to Harrison and the team.
06/20/19
PIPR
06/20/19
NO CHANGE
Target $30
PIPR
Overweight
Moderna recent weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using the recent weakness in shares of Moderna as a buying opportunity. The stock is down 19% on increased volume since the initial public offering lock-up expiry on June 5, Tenthoff tells investors in a research note. The analyst is most focused on the Phase I chikungunya antibody data in the second half of 2019, which he believes will have read-through to Moderna's growing orphan disease pipeline. He reiterates an Overweight rating on the shares with a $30 price target.
VIAV Viavi
$14.92

0.81 (5.74%)

04/22/19
04/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IPG Photonics (IPGP) upgraded to Buy from Neutral at BofA/Merrill. 2. Caleres (CAL) upgraded to Buy from Hold at Needham with analyst Rick Patel saying that his recent meeting with its CEO and CFO have given him an added confidence about the FY19 EPS guidance being "achievable and likely beatable." 3. Viavi (VIAV) upgraded to Neutral from Underweight at JPMorgan with analyst Samik Chatterjee saying the "buildup of industry tailwinds" in the form of 5G network deployments as well as fiber densification and adoption of 3D Sensing should drive medium-term growth above expectations. 4. Alcoa (AA) upgraded to Buy from Hold at Gabelli. 5. Lam Research (LRCX) upgraded to Buy from Neutral at B. Riley FBR with analyst Craig Ellis saying he sees "increasingly visible recent signs" of a cyclical trough in Q1. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/22/19
JPMS
04/22/19
NO CHANGE
JPMS
JPMorgan a buyer of Ciena and Lumentum into Q1 results, downgrades Sensata
JPMorgan analyst Samik Chatterjee names Ciena (CIEN) and Lumentum (LITE) his top Networking Equipment picks into the Q1 reporting season. The analyst is a buyer of both stocks into the prints. Following the rallies year-to-date, investors might need to be more selective relative to opportunities for further share price upside heading into earnings, Chatterjee tells investors in a pre-earnings research note. He believes the overall capital expenditure environment remains positive and that momentum into 5G investment spend appears to be building, particularly in North America. This is likely provide greater visibility to companies relative to their already stated full-year targets, says Chatterjee. However, with investor optimism around 5G infrastructure investment as well as the positive impact on growth from a potential U.S.-China trade deal, the analyst expects share price performances to be largely muted on the back of Q1 earnings. Nonetheless, he sees upside opportunity in both Ciena and Lumentum. Chatterjee also reinstated coverage of CommScope (COMM) and upgraded the shares to Overweight from Neutral, upgraded Viavi Solutions (VIAV) to Neutral from Underweight, and downgraded Sensata (ST) to Neutral from Overweight. A further multiple re-rating of Sensata shares appears unlikely in an environment of moderating auto production this year, contends the analyst.
08/16/19
STFL
08/16/19
NO CHANGE
Target $15
STFL
Buy
Viavi guidance appears conservative, says Stifel
Stifel analyst John Marchetti said Viavi management "struck a conservative tone" on expectations for the year, but he expects positive 2020 estimate revisions as production and field test contributions add to what he expects to be continued strong wireless and fiber test demand. While he lowered his revenue estimates on a reduced growth outlook for 3D sensing to reflect his expectation for slower Android growth given Huawei's difficulties in meeting handset shipment goals, Marchetti keeps a Buy rating and $15 price target on Viavi shares.
07/16/19
JPMS
07/16/19
NO CHANGE
JPMS
JPMorgan favors Ciena, Lumentum and Viavi into Q2 reports
JPMorgan analyst Samik Chatterjee previewed the Q2 earnings reports for the Networking Equipment/IT Hardware space. The analyst favors suppliers with greater exposure to service provider customers, as he's increasingly confident of a spending ramp towards 5G preparedness, relative to suppliers with higher than average exposure to either cable customers or cloud customers, where he believes visibility relative to timing of recovery in customer capex remains low. Chatterjee's top picks going into Q2 earnings are Ciena (CIEN), Lumentum (LITE), and Viavi (VIAV). He's cautious on Arista Networks (ANET) and F5 Networks (FFIV) due to "company-specific challenges" relative to the competitive landscape with the entry of VMware (VMW) into the application delivery controllers market.
PTN Palatin
$1.02

-0.01 (-0.97%)

05/09/19
HCWC
05/09/19
NO CHANGE
Target $6
HCWC
Buy
Palatin price target raised to $6 from $5 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Palatin Technologies to $6 from $5 saying the potential Vyleesi label continues to look "attractive and broad reaching." The analyst believes the company provides a "derisked opportunity for investors" and keeps a Buy rating on the shares.
TLRD Tailored Brands
$5.33

-1.34 (-20.09%)

03/14/19
JEFF
03/14/19
NO CHANGE
Target $19
JEFF
Buy
Jefferies cuts Tailored Brands target to $19, admits to making 'terrible' call
In a research note titled "How Could We Be So Wrong?" Jefferies analyst Randal Konik lowered his price target for Tailored Brands to $19 from $24. "Let's begin with our call has been terrible here," Konik writes. Tailored's business is "challenged and is getting worse," visibility seems very low and management seems to be questioning the execution of some of its strategies, Konik says following the company's Q4 results. He believes the stock will remain in the "penalty box" until the business can show some stabilization. However, with a "cheap" valuation and "less significant downside potential" from current levels, Konik keeps a Buy rating on Tailored Brands.
03/14/19
RILY
03/14/19
DOWNGRADE
Target $11
RILY
Neutral
Tailored Brands downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Susan Anderson downgraded Tailored Brands to Neutral from Buy and cut her price target for the shares to $11 from $20. The analyst sees a lack of near-term visibility into when same-store-sales will stabilize.
12/18/18
12/18/18
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Logitech (LOGI) initiated with an Outperform at Wedbush. 2. Alnylam (ALNY) initiated with a Buy at Guggenheim, while BioMarin (BMRN) was initiated with a Neutral. 3. Tailored Brands (TLRD) initiated with a Buy at B. Riley FBR. 4. Adecogro (AGRO) initiated with a Neutral at Citi. 5. Shopify (SHOP) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/19
RILY
06/13/19
NO CHANGE
Target $7
RILY
Neutral
Tailored Brands price target lowered to $7 from $10 at B. Riley FBR
B. Riley FBR analyst Susan Anderson lowered her price target for Tailored Brands to $7 from $10 saying "challenges remain" after the company's Q2 guidance missed expectations. The analyst believes Tailored Brands is "on the right track" with its changes to the product assortment, cost savings program, and omni-channel initiatives, but she remains on the sidelines pending stabilization in same-store-sales and greater visibility into its long-term performance. Anderson keeps a Neutral rating on the shares.
TOCA Tocagen
$4.16

0.395 (10.51%)

05/22/19
LEER
05/22/19
NO CHANGE
Target $5
LEER
Market Perform
SVB Leerink says Tocagen trial failure likely, cuts target to $5 from $11
SVB Leerink analyst Daina Graybosch lowered her price target for Tocagen to $5 from $11 saying the Independent Data Monitoring Committee's recommendation to continue TOCA 5 trial aligns with her base case. A study failure announcement by year end is now likely, Graybosch tells investors in a research note. She believes the IDMC's recommendation to continue the study "has definitive negative read-through to a final outcome." The analyst keeps a Market Perform rating on Tocagen shares. The stock in premarket trading is down 27% to $6.45.
05/30/19
SBSH
05/30/19
INITIATION
Target $20
SBSH
Buy
Tocagen assumed with a Buy at Citi
Citi analyst Mohit Bansal assumed coverage of Tocagen with a Buy rating and $24 price target. Under a prior analyst, Citi had a Buy rating on the shares with a $27 price target.
04/26/19
04/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Vail Resorts (MTN) initiated with a Buy at SunTrust. 2. Tocagen (TOCA) initiated with an Overweight at Cantor Fitzgerald. 3. Dow Inc. (DOW) initiated with a Hold at Argus. 4. Gilead (GILD) initiated with an Outperform at Bernstein. 5. Reed's (REED) initiated with a Buy at Lake Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/19
CANT
05/22/19
NO CHANGE
Target $28
CANT
Overweight
Tocagen dismissive views present 'strong opportunity,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros reiterates an Overweight rating on Tocagen with a $28 price target after the company announced that the Phase 3 trial of Toca 511 and Toca FC in recurrent high-grade glioma will continue without modification. The analyst had always assumed that the most likely scenario would be that the trial would continue until the final interim analysis in Q4 or 2019. Any dismissive views on Tocagen present a "strong opportunity" ahead of the year-end catalyst, Piros tells investors in a research note. He continues to believe that positive survival data will favor Toca 511 and Toca FC versus chemotherapy.
OLED Universal Display
$195.99

4.79 (2.51%)

08/02/19
08/02/19
DOWNGRADE

Hold
Universal Display downgraded to Hold from Buy at Needham
As previously reported, Needham analyst James Ricchiuti downgraded Universal Display to Hold, saying that while the company beat on Q2 earnings and raised its guidance, the stock was already trading above his price target. The analyst contends that the upside appears to be priced in at current levels.
08/02/19
ROTH
08/02/19
NO CHANGE
Target $206
ROTH
Neutral
Universal Display price target raised to $206 from $172 at Roth Capital
Roth Capital analyst Scott Searle raised his price target for Universal Display to $206 from $172 following a "blowout" quarter. In a research note to investors, Searle says the global OLED opportunity is huge and nascent, but maintains a Neutral rating due to valuation and timing.
09/12/19
SUSQ
09/12/19
DOWNGRADE
SUSQ
Negative
Universal Display downgraded to Negative from Neutral at Susquehanna
08/02/19
NEED
08/02/19
DOWNGRADE
NEED
Hold
Universal Display downgraded to Hold from Buy at Needham

TODAY'S FREE FLY STORIES

AKS

AK Steel

$2.45

0.055 (2.30%)

, MT

ArcelorMittal

$14.58

0.03 (0.21%)

07:41
10/19/19
10/19
07:41
10/19/19
07:41
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AKS

AK Steel

$2.45

0.055 (2.30%)

MT

ArcelorMittal

$14.58

0.03 (0.21%)

NUE

Nucor

$51.69

-0.11 (-0.21%)

STLD

Steel Dynamics

$28.71

-0.04 (-0.14%)

TMST

TimkenSteel

$5.42

-0.015 (-0.28%)

X

U.S. Steel

$10.72

0.1 (0.94%)

GM

General Motors

$36.19

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 31

    Oct

  • 01

    Nov

AAVMY

ABN Amro

$0.00

(0.00%)

, BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

04:55
10/19/19
10/19
04:55
10/19/19
04:55
Conference/Events
Institute of International Finance to hold annual meeting »

2019 IIF Annual Meeting…

AAVMY

ABN Amro

$0.00

(0.00%)

BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

BCS

Barclays

$8.48

0.11 (1.31%)

BLK

BlackRock

$445.26

-5.56 (-1.23%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$69.76

0.16 (0.23%)

CAIXY

CaixaBank

$0.00

(0.00%)

CIB

Bancolombia

$49.65

0.12 (0.24%)

CS

Credit Suisse

$12.34

0.045 (0.37%)

EV

Eaton Vance

$44.07

-0.49 (-1.10%)

GS

Goldman Sachs

$206.61

0.13 (0.06%)

HSBC

HSBC

$38.72

-0.165 (-0.42%)

JPM

JPMorgan

$120.60

0.21 (0.17%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

MCO

Moody's

$217.41

-1.33 (-0.61%)

MS

Morgan Stanley

$43.70

0.25 (0.58%)

NYT

New York Times

$29.76

0.21 (0.71%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

RBS

RBS

$6.14

0.205 (3.46%)

RY

Royal Bank of Canada

$81.49

0.38 (0.47%)

SMFG

Sumitomo Mitsui

$6.87

-0.04 (-0.58%)

SPGI

S&P Global

$250.62

-2.15 (-0.85%)

STT

State Street

$63.40

3.69 (6.18%)

UBS

UBS

$11.35

0.09 (0.80%)

V

Visa

$175.83

-2.11 (-1.19%)

ZURVY

Zurich Insurance

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 10

    Nov

  • 12

    Nov

  • 21

    Nov

  • 04

    Dec

  • 10

    Dec

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

STT

State Street

$63.40

3.69 (6.18%)

20:09
10/18/19
10/18
20:09
10/18/19
20:09
Upgrade
State Street rating change at Keefe Bruyette »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SUN

Sunoco

$32.43

0.32 (1.00%)

19:53
10/18/19
10/18
19:53
10/18/19
19:53
Upgrade
Sunoco rating change at BMO Capital »

Sunoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:24
10/18/19
10/18
18:24
10/18/19
18:24
Hot Stocks
Tandy Leather CFO Castillo to step down »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:23
10/18/19
10/18
18:23
10/18/19
18:23
Hot Stocks
Tandy Leather says most recent annual report statements not reliable »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

18:03
10/18/19
10/18
18:03
10/18/19
18:03
Hot Stocks
U.S. lawmakers request Apple restore HKMapp app in Hong Kong »

U.S. Senators Ron Wyden,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

JPM

JPMorgan

$120.60

0.21 (0.17%)

, FB

Facebook

$185.96

-4.435 (-2.33%)

17:59
10/18/19
10/18
17:59
10/18/19
17:59
Periodicals
JPMorgan CEO says Libra 'a neat idea that will never happen,' Reuters says »

JPMorgan (JPM) CEO Jamie…

JPM

JPMorgan

$120.60

0.21 (0.17%)

FB

Facebook

$185.96

-4.435 (-2.33%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

V

Visa

$175.83

-2.11 (-1.19%)

EBAY

eBay

$38.82

-0.31 (-0.79%)

BKNG

Booking Holdings

$2,012.20

-16.43 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

GLD

SPDR Gold Shares

$140.47

-0.13 (-0.09%)

17:52
10/18/19
10/18
17:52
10/18/19
17:52
Hot Stocks
SPDR Gold Shares holdings rise to 924.64MT from 918.19MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$16.48

0.11 (0.67%)

17:43
10/18/19
10/18
17:43
10/18/19
17:43
Hot Stocks
Teck Resources gets approval for stock buyback for up to 40M class B shares »

Teck Resources has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OSK

Oshkosh

$77.22

0.46 (0.60%)

17:41
10/18/19
10/18
17:41
10/18/19
17:41
Hot Stocks
Oshkosh awarded $159.14M Army contract for medium tactical vehicle production »

Oshkosh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

  • 20

    Nov

OVLY

Oak Valley Bancorp

$16.40

-0.16 (-0.97%)

17:35
10/18/19
10/18
17:35
10/18/19
17:35
Earnings
Oak Valley Bancorp reports Q3 EPS 40c vs. 37c last year »

Reports Q3 NII $10.4M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$0.79

-0.0185 (-2.29%)

17:21
10/18/19
10/18
17:21
10/18/19
17:21
Hot Stocks
FTE Networks receives noncompliance notice from NYSE American »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.45

0.0048 (1.07%)

17:12
10/18/19
10/18
17:12
10/18/19
17:12
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$20.18

1.07 (5.60%)

17:10
10/18/19
10/18
17:10
10/18/19
17:10
Syndicate
Breaking Syndicate news story on Relmada Therapeutics »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
10/18/19
10/18
16:55
10/18/19
16:55
General news
Breaking General news story  »

Dallas Federal Reserve…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

, NWS

News Corp

$13.79

-0.11 (-0.79%)

16:51
10/18/19
10/18
16:51
10/18/19
16:51
Periodicals
Facebook reaches pact with News Corp., others for news section, WSJ says »

News Corp. (NWSA) has…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

NWS

News Corp

$13.79

-0.11 (-0.79%)

FB

Facebook

$185.96

-4.435 (-2.33%)

NYT

New York Times

$29.76

0.21 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

WAIR

Wesco Aircraft

$11.01

0.01 (0.09%)

16:46
10/18/19
10/18
16:46
10/18/19
16:46
Conference/Events
Wesco Aircraft to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:41
10/18/19
10/18
16:41
10/18/19
16:41
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix up 7.5% at $3.35…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

POAI

Predictive Oncology

$0.44

0.0101 (2.35%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Conference/Events
Predictive Oncology to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BK

BNY Mellon

$45.34

0.975 (2.20%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
BNY Mellon SVP Harris sells 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Foamix 

Foamix trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

BAC

Bank of America

$30.37

0.1 (0.33%)

16:35
10/18/19
10/18
16:35
10/18/19
16:35
Hot Stocks
Bank of America's Knox sells 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Jan

LGC

Legacy Acquisition Corp

$10.24

0.02 (0.20%)

16:34
10/18/19
10/18
16:34
10/18/19
16:34
Conference/Events
Legacy Acquisition Corp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFGP

Micro Focus

$15.13

0.56 (3.84%)

, OTEX

OpenText

$39.30

-1.545 (-3.78%)

16:33
10/18/19
10/18
16:33
10/18/19
16:33
Periodicals
OpenText weighing takeover bid for rival Micro Focus, Bloomberg says »

Open Text (OTEX) is…

MFGP

Micro Focus

$15.13

0.56 (3.84%)

OTEX

OpenText

$39.30

-1.545 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.